Mountain Valley MD Holdings Inc
CNSX:MVMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mountain Valley MD Holdings Inc
Net Income
Mountain Valley MD Holdings Inc
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mountain Valley MD Holdings Inc
CNSX:MVMD
|
Net Income
-CA$7.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Wheaton Precious Metals Corp
TSX:WPM
|
Net Income
$1.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Barrick Gold Corp
TSX:ABX
|
Net Income
$7.2B
|
CAGR 3-Years
92%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Kinross Gold Corp
TSX:K
|
Net Income
$2.5B
|
CAGR 3-Years
332%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Franco-Nevada Corp
TSX:FNV
|
Net Income
$1.1B
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
46%
|
|
|
Agnico Eagle Mines Ltd
TSX:AEM
|
Net Income
$4.5B
|
CAGR 3-Years
88%
|
CAGR 5-Years
54%
|
CAGR 10-Years
68%
|
|
Mountain Valley MD Holdings Inc
Glance View
Mountain Valley MD Holdings, Inc. engages in the implementation of its patented Quicksome oral delivery technologies across molecules in nutraceutical, vaccine and pharmaceutical drug applications. The company is headquartered in Vaughan, Ontario. The company went IPO on 2018-03-02. Through its subsidiary, Mountain Valley MD Inc., the Company is engaged in implementing and licensing of its technologies to global pharmaceutical, vaccine and nutraceutical third parties. Its technology include Quicksome oral drug formulation and delivery technologies. The Company’s Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into product formats that are consumed orally. The company is also developing other technologies, including Quicksol solubility formulation technology, and pending dose sparing adjuvant.
See Also
What is Mountain Valley MD Holdings Inc's Net Income?
Net Income
-7.2m
CAD
Based on the financial report for Dec 31, 2025, Mountain Valley MD Holdings Inc's Net Income amounts to -7.2m CAD.
What is Mountain Valley MD Holdings Inc's Net Income growth rate?
Net Income CAGR 5Y
18%
Over the last year, the Net Income growth was -79%. The average annual Net Income growth rates for Mountain Valley MD Holdings Inc have been -2% over the past three years , 18% over the past five years .
